174 related articles for article (PubMed ID: 25537792)
1. Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception.
Henry N; Schlueter M; Lowin J; Lekander I; Filonenko A; Trussell J; Skjeldestad FE
J Fam Plann Reprod Health Care; 2015 Apr; 41(2):109-15. PubMed ID: 25537792
[TBL] [Abstract][Full Text] [Related]
2. The Cost of Unintended Pregnancies in Canada: Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting Reversible Contraceptives.
Black AY; Guilbert E; Hassan F; Chatziheofilou I; Lowin J; Jeddi M; Filonenko A; Trussell J
J Obstet Gynaecol Can; 2015 Dec; 37(12):1086-97. PubMed ID: 26637081
[TBL] [Abstract][Full Text] [Related]
3. Cost of unintended pregnancy in Sweden - a possibility to lower costs by increasing LARC usage.
Engstrand S; Kopp Kallner H
Contraception; 2018 May; 97(5):445-450. PubMed ID: 29409858
[TBL] [Abstract][Full Text] [Related]
4. Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception.
Trussell J; Henry N; Hassan F; Prezioso A; Law A; Filonenko A
Contraception; 2013 Feb; 87(2):154-61. PubMed ID: 22959904
[TBL] [Abstract][Full Text] [Related]
5. Direct costs of unintended pregnancy in Spain.
Lete I; Hassan F; Chatzitheofilou I; Wood E; Mendivil J; Lambrelli D; Filonenko A
Eur J Contracept Reprod Health Care; 2015; 20(4):308-18. PubMed ID: 25843298
[TBL] [Abstract][Full Text] [Related]
6. Cost-benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia.
Concepcion K; Lacey S; McGeechan K; Estoesta J; Bateson D; Botfield J
Aust Health Rev; 2020 Jun; 44(3):385-391. PubMed ID: 31655632
[TBL] [Abstract][Full Text] [Related]
7. Achieving cost-neutrality with long-acting reversible contraceptive methods.
Trussell J; Hassan F; Lowin J; Law A; Filonenko A
Contraception; 2015 Jan; 91(1):49-56. PubMed ID: 25282161
[TBL] [Abstract][Full Text] [Related]
8. Health economics of contraception.
Mavranezouli I
Best Pract Res Clin Obstet Gynaecol; 2009 Apr; 23(2):187-98. PubMed ID: 19147410
[TBL] [Abstract][Full Text] [Related]
9. Direct costs of unintended pregnancy in the Russian federation.
Lowin J; Jarrett J; Dimova M; Ignateva V; Omelyanovsky V; Filonenko A
Appl Health Econ Health Policy; 2015 Feb; 13(1):61-8. PubMed ID: 25269779
[TBL] [Abstract][Full Text] [Related]
10. Medicaid savings from the Contraceptive CHOICE Project: a cost-savings analysis.
Madden T; Barker AR; Huntzberry K; Secura GM; Peipert JF; McBride TD
Am J Obstet Gynecol; 2018 Dec; 219(6):595.e1-595.e11. PubMed ID: 30194049
[TBL] [Abstract][Full Text] [Related]
11. Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Contraception; 2015 Mar; 91(3):185-92. PubMed ID: 25500324
[TBL] [Abstract][Full Text] [Related]
12. Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design.
Madden T; Paul R; Maddipati R; Buckel C; Goodman M; Peipert JF
Contraception; 2019 Sep; 100(3):196-201. PubMed ID: 31132346
[TBL] [Abstract][Full Text] [Related]
13. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
Broecker J; Jurich J; Fuchs R
Contraception; 2016 Mar; 93(3):266-72. PubMed ID: 26577755
[TBL] [Abstract][Full Text] [Related]
14. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
Hubacher D; Spector H; Monteith C; Chen PL
Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
[TBL] [Abstract][Full Text] [Related]
16. Increasing Use of Long-Acting Reversible Contraception to Decrease Unplanned Pregnancy.
Lotke PS
Obstet Gynecol Clin North Am; 2015 Dec; 42(4):557-67. PubMed ID: 26598299
[TBL] [Abstract][Full Text] [Related]
17. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.
Birgisson NE; Zhao Q; Secura GM; Madden T; Peipert JF
J Womens Health (Larchmt); 2015 May; 24(5):349-53. PubMed ID: 25825986
[TBL] [Abstract][Full Text] [Related]
18. Operation PINC: Process Improvement for Non-Delayed Contraception.
Adams KL
Mil Med; 2017 Nov; 182(11):e1864-e1868. PubMed ID: 29087854
[TBL] [Abstract][Full Text] [Related]
19. Cost Savings and Effectiveness of Long-Acting Reversible Contraception (LARC) on the Prevention of Pregnancy in Adolescents: A Systematic Review.
Marmett B; Guaranha DDFK; Carvalho AF; Reis JM; Souza CLE; Dalcin TC; Amantéa SL
J Pediatr Adolesc Gynecol; 2024 Feb; 37(1):11-17. PubMed ID: 37802383
[TBL] [Abstract][Full Text] [Related]
20. The cost of unintended pregnancy in the United States.
Trussell J
Contraception; 2007 Mar; 75(3):168-70. PubMed ID: 17303484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
